Targeting lipogenesis promotes the synergistic effect of the selective HDAC6 inhibitor ITF3756 with bortezomib in colon cancer cells
Marzia Franzò(University of Palermo), Sonia Emanuele(University of Palermo)
Cited by 0
Related Papers
Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
|Biomedicines|2022|46
Oncogenic BRAF and p53 Interplay in Melanoma Cells and the Effects of the HDAC Inhibitor ITF2357 (Givinostat)
|International Journal of Molecular Sciences|2023|13